Already a member? Click here to login.
Already a member? Click here to login.
29 August 2024—Join us in congratulating the winners and finalists of the 2024 Abbott Case Study Competition, which recognises excellence in the care, education, and self-management of diabetes through the use of flash glucose monitoring, LibreView, and the ambulatory glucose profile report.
This year’s competition featured a range of outstanding submissions from dedicated professionals.
Congratulations to Sabrina Sharp for receiving the top honour, the Judge’s Choice Award, for her case study titled Supporting our patient by enhanced technology to achieve safe glucose levels and autonomy in palliative self-care during chemotherapy.
Sabrina Sharp (far left) receiving her award. Pictured with ADEA President Amanda Bartlett, Bryan Ladell from Abbott, and ADEA Vice President Ann Bush at the Australasian Diabetes Congress on 23 August.
Ms Sharp expressed her gratitude, saying she was honoured to receive the award and that it was a privilege to support her client during his diabetes and cancer journey.
She said the FreeStyle Libre 2 helped her client “maintain optimal glucose levels, offering him safety and control”.
“Although he lost his battle in July 2024, his family found comfort knowing he received the best care possible, while avoiding painful finger pricks during end-of-life care,” Ms Sharp said.
“The FreeStyle Libre 2 also gave them the confidence to enact treatment changes without undue risk of hyperglycaemia or hypoglycaemia.
Ms Sharp said working with her incredible clients, their families, her colleagues, and the team at Abbott Diabetes Care had been “an incredibly rewarding experience”.
“This recognition not only honours our collective efforts but also highlights the unique needs of a very special patient group,” she said.
We also congratulate the other finalists in the Judge’s Choice Award:
The Early Career Award was presented to Amy Zheng for her case study, Revealing the unexpected: technology’s role in discovering secondary causes of hyperglycaemia.
Amy Zheng (second from right) receiving her award. Pictured with ADEA President Amanda Bartlett, Bryan Ladell from Abbott, and ADEA Vice President Ann Bush at the Australasian Diabetes Congress on 23 August.
These professionals have made significant contributions to diabetes care, highlighting the positive impact of personalised approaches with these technologies.
They each received scholarships for professional development and full registration to the Australasian Diabetes Congress 2024.
Their case studies are featured in the top 10 of the Abbott FreeStyle Case Study booklet, with the Judge’s Choice and Early Career Award case studies also published in the Australian Diabetes Educator publication, offering wider recognition of their work.
We once again congratulate all participants and extend our gratitude to Abbott for this initiative, which underscores the vital role of technology in diabetes management.
29 August 2024—Join us in congratulating the winners and finalists of the 2024 Abbott Case Study Competition, which recognises excellence in the care, education, and self-management of diabetes through the use of flash glucose monitoring, LibreView, and the ambulatory glucose profile report.
This year’s competition featured a range of outstanding submissions from dedicated professionals.
Congratulations to Sabrina Sharp for receiving the top honour, the Judge’s Choice Award, for her case study titled Supporting our patient by enhanced technology to achieve safe glucose levels and autonomy in palliative self-care during chemotherapy.
Sabrina Sharp (far left) receiving her award. Pictured with ADEA President Amanda Bartlett, Bryan Ladell from Abbott, and ADEA Vice President Ann Bush at the Australasian Diabetes Congress on 23 August.
Ms Sharp expressed her gratitude, saying she was honoured to receive the award and that it was a privilege to support her client during his diabetes and cancer journey.
She said the FreeStyle Libre 2 helped her client “maintain optimal glucose levels, offering him safety and control”.
“Although he lost his battle in July 2024, his family found comfort knowing he received the best care possible, while avoiding painful finger pricks during end-of-life care,” Ms Sharp said.
“The FreeStyle Libre 2 also gave them the confidence to enact treatment changes without undue risk of hyperglycaemia or hypoglycaemia.
Ms Sharp said working with her incredible clients, their families, her colleagues, and the team at Abbott Diabetes Care had been “an incredibly rewarding experience”.
“This recognition not only honours our collective efforts but also highlights the unique needs of a very special patient group,” she said.
We also congratulate the other finalists in the Judge’s Choice Award:
The Early Career Award was presented to Amy Zheng for her case study, Revealing the unexpected: technology’s role in discovering secondary causes of hyperglycaemia.
Amy Zheng (second from right) receiving her award. Pictured with ADEA President Amanda Bartlett, Bryan Ladell from Abbott, and ADEA Vice President Ann Bush at the Australasian Diabetes Congress on 23 August.
These professionals have made significant contributions to diabetes care, highlighting the positive impact of personalised approaches with these technologies.
They each received scholarships for professional development and full registration to the Australasian Diabetes Congress 2024.
Their case studies are featured in the top 10 of the Abbott FreeStyle Case Study booklet, with the Judge’s Choice and Early Career Award case studies also published in the Australian Diabetes Educator publication, offering wider recognition of their work.
We once again congratulate all participants and extend our gratitude to Abbott for this initiative, which underscores the vital role of technology in diabetes management.
